Author

Bernadette Surujbally

Observed name: Surujbally, Bernadette

Institution: AiCuris (Germany)

Observed institutions: Shanghai Jiao Tong University, Fudan University, Ruijin Hospital, Nanfang Hospital, Roche (United Kingdom), First Hospital of Jilin University, AiCuris (Germany), Southern Medical University

ORCID: 0000-0002-3021-0821

Observed ORCID: 0000-0002-3021-0821

OpenAlex ID: A5089108312

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B

2024 · Jinlin Hou, Wenhong Zhang, et al. · New England Journal of Medicine · 113

First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection

2023 · Edward J. Gane, Won Kim, et al. · Journal of Hepatology · 47

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

2021 · Edward Gane, Man‐Fung Yuen, et al. · Hepatology · 45

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

2018 · Lai Wei, Heiner Wedemeyer, et al. · PLoS ONE · 10

RO7062931 antisense oligonucleotide phase 1 study demonstrates target engagement in patients with chronic hepatitis B on established nucleos(t)ide therapy

2020 · Man-Fung Yuen, Edward Gane, et al. · Journal of Hepatology · 8

Pritelivir Demonstrated Superior Efficacy Compared to Investigator’s Choice Treatment for Refractory Herpes Simplex Virus Infections In Immunocompromised Patients: PRIOH-1, Phase 3 Safety and Efficacy

2026 · Genovefa A Papanicolaou, Robin K. Avery, et al. · Transplantation and Cellular Therapy · 7

A single ascending dose study of single‐stranded oligodeoxyribonucleotide RO7062931 in Chinese healthy volunteers

2023 · Tsang Tommy Cheung, Andrea On Yan Luk, et al. · Clinical and Translational Science · 2

Efficacy and Safety of Pritelivir vs Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial

2026 · Camille N Kotton, Kimberly A Workowski, et al. · Open Forum Infectious Diseases · 1

233. Efficacy and safety results from the Phase 2 clinical trial of pritelivir versus foscarnet for treatment of acyclovir-refractory and/or resistant mucocutaneous HSV infections in immunocompromised subjects

2026 · Camille N Kotton, Robin K Avery, et al. · Open Forum Infectious Diseases · 1

P-113. Interim Results of the First-in-human Phase 1 Trial of AIC468: A Novel Antisense Oligonucleotide that Targets BK-Virus Transcripts

2026 · Susanne Bonsmann, Ashish Soman, et al. · Open Forum Infectious Diseases

Works count: 13

Citation count: 236

H-index: 6

I10-index: 4